Catalent is vulnerable to facility closures whether from natural disasters or manufacturing issues, and a warning letter from the FDA or other regulatory agency can result in manufacturing delays or ...
Biocompatibility is a key consideration in the development and marketing of medical textiles, as it determines how materials interact with the human body. Testing typically involves both in vitro — ...
Muvalaplin is a small molecule inhibitor that prevents the bonding of the two protein components that combine to make Lp(a ... foundations and corporations (including pharmaceutical, device ...